What is iRadimed's debt-to-equity?

iRadimed (IRMD) reported debt-to-equity of 0× in Q1 2025.

How has iRadimed's debt-to-equity changed year-over-year?

iRadimed's debt-to-equity decreased by 97.3% year-over-year, from 0× to 0×.

What is the long-term trend for iRadimed's debt-to-equity?

Over 4 years (2020 to 2024), iRadimed's debt-to-equity has grown at a -55.1% compound annual growth rate (CAGR), from 0× to 0×.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.

iRadimed IRMD Debt-to-equity

Debt-to-equity at other companies

GE HealthCare TechnologiesGEHC

1×0.0×

Merit Medical SystemsMMSI

0.5×-0.1×

ICU MedicalICUI

0.6×-0.2×

ITG

Integer HoldingsITGR

0.8×0.0×

Lumexa Imaging Holdings, Inc. LMRI

1.6×—

RadNetRDNT

1.8×-0.2×

Other financials

Income statement

See full

Revenue$22.0M+12.6%

Gross profit$16.8M+13.3%

Operating income$7.2M+33.2%

Net income$5.8M+24.1%

EPS (diluted)$0.45+21.6%

Balance sheet

See full

Cash & equivalents$56.4M+12.0%

Total debt$59.2K-96.9%

Total equity$98.5M+9.4%

Total assets$114.4M+12.4%

Cash flow

See full

Operating cash flow$8.3M+93.2%

CapEx$403.0K-89.1%

Free cash flow$7.9M+1,226%

Valuation

See full

Market cap$1.21B+63.4%

P/E51.3×+13.8×

P/S14×+4.2×

Profitability

See full

Gross margin76.8%-0.1pp

Operating margin32.4%+2.3pp

Net margin27.4%+1.0pp

FCF margin28.4%+8.9pp

Returns & leverage

See full

Return on equity25%+1.2pp

Current ratio7.1×-1.7×

Where this comes from

Calculated from iRadimed’s reported figures.

total debt/total stockholders equity=0×

Based on the most recent quarter.

The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRadimed's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is iRadimed's debt-to-equity?: iRadimed (IRMD) reported debt-to-equity of 0× in Q1 2025.
How has iRadimed's debt-to-equity changed year-over-year?: iRadimed's debt-to-equity decreased by 97.3% year-over-year, from 0× to 0×.
What is the long-term trend for iRadimed's debt-to-equity?: Over 4 years (2020 to 2024), iRadimed's debt-to-equity has grown at a -55.1% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-equity mean?: Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.